Abstract: Techniques for fabric adhesion to an apparatus are described. According to one or more embodiments, an apparatus is laminated with fabric utilizing one or more fabric layers. In at least some embodiments, multiple adhesive zones are defined on a fabric layer. Each adhesive zone, for instance, has a particular set of properties, such as a particular location on a fabric layer, a particular adhesive thickness, a particular adhesive type, and so forth. In at least some embodiments, different adhesive zones differ from one another based on one or more of their respective properties and thus enable different fabric characteristics to be specified at different adhesive zones.

Abstract: Techniques for a touch input device in a circuit board are described. In at least some embodiments, a touch input device is integrated into a circuit board of an apparatus. For instance, a touch interaction region of the touch input device is formed by cutting and/or etching a portion of the circuit board such that the touch interaction region is moveable with respect to adjacent portions of the circuit board. According to one or more embodiments, a touch input device includes a switch such that movement of the touch interaction region actuates the switch to generate a click input event.

Abstract: The present invention provides compounds of Formula A: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as leishmaniasis, human African trypanosomiasis and Chagas disease.

Abstract: A cable clamp includes a base and a keeper. The base has a first end, a second end, and a center channel. The keeper is coupled to the base and has a semi-obround clamping arm including an arcuate first leg, an arcuate second leg, and a central portion extending between said first leg and said second leg.

Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as Leishmaniasis, Human African Trypanosomiasis and Chagas disease.

Abstract: A cable clamp includes an elongated, open-top base having a first end, a second end, and a central region. A suspension arm extends from the open-top base. An eyelet having an opening, a top portion, and a base portion is coupled to the suspension arm. The eyelet base portion has a first width and the top portion has a second width greater than the first width. A keeper is coupled to the base.

Abstract: The present invention provides compounds of Formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as Leishmaniasis, Human African Trypanosomiasis and Chagas disease.

Abstract: Input device haptics and pressure sensing techniques are described. An input device includes an outer surface, a pressure sensor and haptic feedback mechanism, and a pressure sensing and haptic feedback module. The outer surface is configured to receive an application of pressure by an object. The pressure sensor and haptic feedback mechanism has one or more piezos configured to detect and quantify an amount of the application of the pressure to the outer surface by the object, the one or more piezos configured to output a signal indicating the quantified amount of the pressure. The pressure sensing and haptic feedback module is configured to receive the signal from the one or more piezos indicating the quantified amount of the pressure and control the haptic feedback of the pressure sensor and haptic feedback mechanism.

Abstract: Texture and graphic formation techniques are described. In one or more implementations, an apparatus includes one or more modules implemented at least partially in hardware, the one or more modules configured to perform operations as part of a computing device. The apparatus also includes an outer layer disposed over and at least partially covering the one or more modules, the outer layer includes a graphics substrate having an outer surface that has a non-smooth texture and one or more graphics formed on an opposing side of the graphics substrate from the outer surface.

Abstract: The present invention provides compounds of Formula A: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as leishmaniasis, human African trypanosomiasis and Chagas disease.

Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as Leishmaniasis, Human African Trypanosomiasis and Chagas disease.

Abstract: The present invention provides compounds of Formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite, such as Leishmaniasis, Human African Trypanosomiasis and Chagas disease.